Seegene

Seegene ROE

The Return on Equity (ROE) of Seegene (096530.KQ) as of Oct 28, 2026 is 4.75 %. In the previous year, Return on Equity (ROE) was -2.08 % — a change of -328.77% (higher).

ROE

4.75 %

YoY

-328.77%

Last updated:

In 2025, Seegene's return on equity (ROE) was 4.75 %, a -328.77% increase from the -2.08 % ROE in the previous year.

The Seegene ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
8.38 KRW
Jan 1, 2019
17.48 KRW
Jan 1, 2020
77.83 KRW
Jan 1, 2021
49.62 KRW
Jan 1, 2022
15.87 KRW
Jan 1, 2023
0.07 KRW
Jan 1, 2024
-2.08 KRW
Jan 1, 2025
4.75 KRW
The Seegene ROE history
YEARROEYoY
4.75 %-328.77%
-2.08 %-3,292.27%
0.07 %-99.59%
15.87 %-68.02%
49.62 %-36.25%
77.83 %+345.17%
17.48 %+108.66%
8.38 %+426.84%
1.59 %-68.30%
5.02 %+0.05%
5.01 %-48.02%
9.65 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Seegene Stock analysis

What does Seegene do? Seegene, Inc. generates revenue through the manufacturing and distribution of molecular diagnostics and reagents. The company offers infectious pathogens inspection products, including those for allergic respiratory pathogens, sexually transmitted diseases, and human papilloma virus (HPV), alongside drug resistance, single nucleotide polymorphisms (SNP), and somatic mutation cancer inspection products. It also provides automatic real-time detection instruments under the brand names Seeplex, Anyplex, and Magicplex. The firm serves both domestic and overseas markets with these products. The primary customers for Seegene's products are healthcare providers and laboratories requiring diagnostic solutions. The company's product portfolio targets specific medical needs such as infectious disease testing and cancer diagnostics. Its brands Seeplex, Anyplex, and Magicplex are used across various diagnostic applications, including respiratory and sexually transmitted disease testing. The firm's focus on molecular diagnostics positions it within the healthcare sector for specialized testing services. Seegene's revenue streams are derived from the sale of its branded diagnostic products and instruments. The company's domestic and overseas market distribution strategy supports its business model, with Seeplex, Anyplex, and Magicplex serving as key product lines. The firm's offerings cater to the growing demand for accurate and efficient molecular diagnostic solutions in healthcare settings. Seegene is one of the most popular companies on Eulerpool.

ROE Details

Decoding Seegene's Return on Equity (ROE)

Seegene's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Seegene's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Seegene's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Seegene’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Seegene stock

Return on Equity (ROE) of Seegene is 4.75 % in 2025.

Return on Equity (ROE) of Seegene changed from -2.08 % to 4.75 %, representing a -328.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Seegene since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Seegene with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Seegene

All Key Metrics — Seegene